1 / 8

Rethinking health innovation from the South - Some south driven initiatives

Rethinking health innovation from the South - Some south driven initiatives. Dr Chris Edlin December 14 th 2010. A Few Facts. Commenced operations: June 2008 with 4 staff Finance: R30M ($4M) initial investment (government), a further R19M ($2.5M) raised through collaborations

byron
Télécharger la présentation

Rethinking health innovation from the South - Some south driven initiatives

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rethinking health innovation from the South - Some south driven initiatives Dr Chris Edlin December 14th 2010

  2. A Few Facts Commenced operations: June 2008 with 4 staff Finance: R30M ($4M) initial investment (government), a further R19M ($2.5M) raised through collaborations Only small molecule Chemistry company in South Africa (and Africa) International BoD and SAB Facility: 800m2 of laboratory space with state-of-the-art analytical and synthesis equipment Equipment: 400MHz NMR, Agilent LCMS and prep HPLC, Genevac, CEM discover 12 µW

  3. Location • South Africa is GMT +2h • Cape Town to iThemba = London to Rome

  4. Malaria Phenotypic Screening • The Future…….. • Several series identified • -Novel (MMV feedback, literature (TCAMS, St Jude) • -Good Ligand Efficiency • H2L effort initiated • ADMET properties assessed • -Members from series show good properties • -Solubility, LogD, Microsomal Stability, Caco2 • Submitted LOI and full proposal to MMV for funding support • -Selected as one of final 6 (/60) for support Objective: Identify novel, low cost anti malarials Origin: iThemba networks and desire/need to generate project starting points. MMV capacity to screen • Status: • Screened novel compound collections (~42k) and identified relevant starting points Partners: MRCT (UK), MMV (CH), Eskitis (AU) Facilitator: iThemba

  5. GSK – Pool for Open Innovation • Extracts from a speech (Jan 2010) given by Andrew Witty (GSK CEO) at the Council on Foreign Relations in New York: “Since I took over at GSK I have been focused on changing the business model for the company to improve performance. But equally important is the imperative to earn the trust of society, not just by meeting expectations, but by exceeding them.” -Open lab ($8M seed funding) -Open source malaria hits -Patent pool -Collaborations “A collaboration has also been established with South Africa firm iThemba Pharmaceuticals. This work will help research and discovery into new medicines to treat tuberculosis”

  6. GSK – Pool for Open Innovation Objective: Access and exploit IP in the “GSK pool for open innovation” for novel TB therapy • The Future…….. • Transfer of two scientists Jan 2011 • Future license opportunity (fee?)? • Member of international consortium • -Emory, Alnylam, GSK, BVGH, Harvard, MIT……. Origin: Board of directors network • Status: • Signed MOU with GSK to access Pool, Announced by Andrew Witty (CEO)

  7. Mtb Phenotypic Screening Objective: Identify novel, low cost Mtb inhibitors • The Future…….. • Screen output expected Jan/Feb 2011 • -Shared effort UIC/iThemba • -Shared IP (UIC/iThemba) • - MRCT retain right for MoA determination • Seek funding for initial H2L phase • -GTB, NIH, Wellcome Trust…. Origin: iThemba networks and desire/need to generate project starting points • Status: • 100k compounds being transported to UIC for phenotypic screening (MABA, LORA and cytotox.) Partners: MRCT (UK), UIC (USA), iThemba Facilitator: iThemba

  8. Key Learnings • Require strong and renowned advisors (figure heads) • Gives partner confidence in capabilities • Require excellent network (international) • Use appropriate tools e.g. Linkedin • Require tenacity • Email/telephone call per collaboration = ………..

More Related